Skip to main content
PIRAMAL PHARMA LIMITED logo

PIRAMAL PHARMA LIMITED — Investor Relations & Filings

Ticker · PPLPHARMA ISIN · INE0DK501011 LEI · 3358006D6AL7PZ4U9T51 BSE.NS Manufacturing
Filings indexed 365 across all filing types
Latest filing 2025-08-20 Regulatory Filings
Country IN India
Listing BSE.NS PPLPHARMA

About PIRAMAL PHARMA LIMITED

https://www.piramalpharma.com/

Piramal Pharma Limited provides a broad range of products and services across the drug lifecycle through three main business segments: Piramal Pharma Solutions, Piramal Critical Care, and Consumer Healthcare. Piramal Pharma Solutions operates as an integrated Contract Development and Manufacturing Organization (CDMO), offering end-to-end services from drug discovery and development to commercial manufacturing of APIs and formulations. Piramal Critical Care focuses on complex hospital generics, holding a significant global market share in inhalation anesthetics, including Sevoflurane and Isoflurane, as well as injectable anesthesia and pain management therapies. The Consumer Healthcare division manages a diverse portfolio of over-the-counter brands such as Saridon, Lacto Calamine, and Tetmosol. The company leverages an extensive global manufacturing network to deliver specialized healthcare solutions worldwide.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing about the schedule of analyst and institutional investor meetings. It references SEBI regulations and provides dates and venues for upcoming investor interactions. There is no financial data, no detailed report, no earnings information, nor any regulatory filing beyond the announcement of meetings. The document length is only 1738 characters, which is quite short and does not contain any financial statements or detailed analysis. This fits the category of an Investor Presentation announcement or update, but since it is only a schedule notification without presentation content, it is best classified as a Regulatory Filing (RNS) as a general announcement under SEBI regulations.
2025-08-20 English
General Updates
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding a fire incident at a third-party warehouse. It is a regulatory announcement informing stock exchanges about a material event affecting the company. The document is short (2010 characters) and serves as a notification rather than a detailed report or financial statement. It does not contain financial results, management discussion, or audit information. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-08-07 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the schedule of analyst and institutional investor meetings. It references SEBI regulations and provides dates and venues for upcoming investor interactions. There is no financial data, no detailed report, no earnings information, and no mention of any report being attached or published. The document is an announcement of meetings rather than a report or transcript. Given the content and length (1682 characters), it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-08-04 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the transcript of a conference call on the unaudited financial results for the quarter ended June 30, 2025. It references the transcript being available on the company's website and is a short communication (1419 characters). It does not contain the transcript itself or detailed financial data, but rather announces the availability of the transcript. According to the rules, such a document is best classified as a Call Transcript (CT) since it specifically mentions the transcript of a conference call. However, since the transcript is not included but only announced, and the document is short, it fits the pattern of a Regulatory Filing (RNS) as a notification about the transcript availability rather than the transcript itself. Therefore, the correct classification is Regulatory Filings (RNS).
2025-07-31 English
Shareholders meeting
Regulatory Filings
2025-07-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short announcement dated 29th July 2025, informing about the availability of the audio recording of a conference call discussing the unaudited financial results for the quarter ended 30th June 2025. It references the conference call and provides a link to the recording on the company's website. The document does not contain the financial results themselves, nor detailed financial data or analysis. It is essentially a notification about the availability of a conference call recording related to quarterly financial results. According to the classification rules, such a document is best classified as a Call Transcript (CT) type, since it relates to a conference call on financial results. However, since the document only announces the availability of the audio recording and does not contain the transcript itself, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a regulatory announcement about the call recording availability, not the transcript or the financial report itself. The document length is short (1445 characters), supporting that it is an announcement rather than a full transcript or report.
2025-07-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.